Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in patients with chronic hepatitis B: More questions than an answer – author’s reply
- Author:
Hyeyeon HONG
1
;
Jonggi CHOI
Author Information
- Publication Type:Correspondence
- From:Clinical and Molecular Hepatology 2024;30(2):272-273
- CountryRepublic of Korea
- Language:EN
